摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-tert-Butylcyclohexansaeurechlorid | 35618-41-8

中文名称
——
中文别名
——
英文名称
1-tert-Butylcyclohexansaeurechlorid
英文别名
1-t-Butylcyclohexancarbonylchlorid;1-tert-Butylcyclohexane-1-carbonyl chloride
1-tert-Butylcyclohexansaeurechlorid化学式
CAS
35618-41-8
化学式
C11H19ClO
mdl
——
分子量
202.724
InChiKey
AUNSXFRRWBYYGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    134-136 °C(Press: 20 Torr)
  • 密度:
    1.027±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 5-ethyl-imidazo (5,1-F) (1,2,4,) triazin-4 (3h)-ones as phosphodiesterase inhibitors
    申请人:Alonso-Alija Cristina
    公开号:US20050272732A1
    公开(公告)日:2005-12-08
    The invention relates to novel 5-ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
    本发明涉及新型5-乙基咪唑三嗪酮的制备方法及其在药物中的应用,尤其是用于治疗和/或预防炎症过程和/或免疫性疾病。
  • 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
    申请人:Alonso-Alija Cristina
    公开号:US20060293326A1
    公开(公告)日:2006-12-28
    The invention relates to 2-Heteroaryl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R 1 denotes 5- to 10-membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C 1 -C 4 )-alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3- to 10-membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, whereby carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C 1 -C 6 )-aldyl, (C 1 -C 6 )-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C 2 -C 10 )-alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C 1 -C 6 )-alkoxy, hydroxy, halogen, 3- to 10-membered carbocyclyl and oxo.
    本发明涉及2-杂环芳基咪唑三嗪酮的制备方法及其在药物中的应用,特别是用于治疗和/或预防炎症过程和/或免疫性疾病。本发明涉及通式(I)的化合物,其中R1表示5-至10-成员杂环芳基,该杂环芳基可以被选自卤素,(C1-C4)-烷基,三氟甲基,氰基,硝基和三氟甲氧基的相同或不同残基取代,或表示3-至10-成员碳环烷基或碳键结合的4-至10-成员杂环烷基,其中碳环烷基和杂环烷基可以被选自(C1-C6)-醛基,(C1-C6)-醛氧基,羟基,卤素,三氟甲基和氧代物的相同或不同残基取代,或表示(C2-C10)-烷基,该烷基可以被选自(C1-C6)-氧烷基,羟基,卤素,3-至10-成员碳环烷基和氧代物的相同或不同残基取代。
  • PIROZHKOV S. D.; PUZITSKIJ K. V.; MYSHENKOVA T. P.; RYABOVA K. G., IZV. AN CCCP. CEP. XIM., 1978, HO 5, 1057-1063
    作者:PIROZHKOV S. D.、 PUZITSKIJ K. V.、 MYSHENKOVA T. P.、 RYABOVA K. G.
    DOI:——
    日期:——
  • 2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES
    申请人:Bayer HealthCare AG
    公开号:EP1399439A1
    公开(公告)日:2004-03-24
  • [EN] 2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES<br/>[FR] 2-HETEROARYL-IMIDAZOTRIAZINONES ET UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES OU IMMUNITAIRES
    申请人:BAYER AG
    公开号:WO2002098873A1
    公开(公告)日:2002-12-12
    The invention relates to 2-Heteroaryl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R1 denotes 5- to 10- membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C¿1?-C4)-alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3-to 10-membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, whereby carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C1-C6)-aldyl, (C1-C6)-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C2-C10)-alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C1-C6)-alkoxy, hydroxy, halogen, 3-to 10-membered carbocyclyl and oxo.
查看更多